# Personalised Therapeutics @LUMC

> **NCT05508763** · — · ACTIVE_NOT_RECRUITING · sponsor: **Leiden University Medical Center** · enrollment: 2000 (estimated)

## Conditions studied

- Adverse Drug Reaction

## Interventions

- **GENETIC:** Genetic test for 14 pharmacogenes

## Key facts

- **NCT ID:** NCT05508763
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-12-01
- **Primary completion:** 2026-02
- **Final completion:** 2026-10
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2025-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05508763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05508763, "Personalised Therapeutics @LUMC". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05508763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*